HOSPITAL UNIVERSITARIO RUBER
Departamento
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (21)
2024
-
Adolescent Reference Values for MR-Derived Biventricular Strain Obtained Using Feature-Tracking and Myocardial Tagging
Journal of Magnetic Resonance Imaging
2023
-
Absence of Myocardial Involvement After SARS-CoV-2 Vaccination in Asymptomatic Adolescents
Journal of Cardiovascular Translational Research
-
Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents
eClinicalMedicine, Vol. 57
2022
-
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*
British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969
-
Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases
Cancers, Vol. 14, Núm. 5
-
Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study
International Journal of Infectious Diseases, Vol. 123, pp. 97-103
-
Post-Myocardial Infarction Risk Prediction: Does Ventricular Shape Matter?
JACC: Cardiovascular Imaging
2021
-
Clinical, pathological, and molecular features of breast carcinoma cutaneous metastasis
Cancers, Vol. 13, Núm. 21
-
Epithelial mesenchymal transition and immune response in metaplastic breast carcinoma
International Journal of Molecular Sciences, Vol. 22, Núm. 14
-
Evolution of angiogenic factors in pregnant patients with breast cancer treated with chemotherapy
Cancers, Vol. 13, Núm. 4, pp. 1-12
-
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer
British Journal of Cancer, Vol. 124, Núm. 9, pp. 1581-1591
-
Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study
Cancers, Vol. 13, Núm. 21
2020
-
Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial
Open Heart, Vol. 7, Núm. 2
-
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Breast Cancer Research, Vol. 22, Núm. 1
-
Molecular features of metaplastic breast carcinoma: An infrequent subtype of triple negative breast carcinoma
Cancers, Vol. 12, Núm. 7, pp. 1-13
-
Monocyte chemoattractant protein-1 is an independent predictor of coronary artery ectasia in patients with acute coronary syndrome
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-13
2019
-
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Frontiers in Oncology, Vol. 9, Núm. APR
-
Point-of-care ultrasound: Is it time to include it in the paediatric specialist training program?
Anales de Pediatria, Vol. 91, Núm. 3, pp. 206.e1-206.e13
2018
-
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
EMBO Molecular Medicine, Vol. 10, Núm. 12
2017
-
Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221